Manulife (Manufacturers Life Insurance)
CTSO icon

Manulife (Manufacturers Life Insurance)’s Cytosorbents Corp CTSO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,385
Closed -$65K – 3040
2022
Q1 		$65K Sell
20,385
-5,076
-20% -$18.2K ﹤0.01% 3017
2021
Q4 		$107 Buy
25,461
+639
+3% +$3.58K ﹤0.01% 3043
2021
Q3 		$202K Sell
24,822
-2,286
-8% -$18.6K ﹤0.01% 2978
2021
Q2 		$205K Buy
27,108
+1,156
+4% +$9.74K ﹤0.01% 3086
2021
Q1 		$225K Sell
25,952
-645
-2% -$6.15K ﹤0.01% 2823
2020
Q4 		$212K Buy
26,597
+2,852
+12% +$23.9K ﹤0.01% 2741
2020
Q3 		$189K Buy
23,745
+2,468
+12% +$22.3K ﹤0.01% 2592
2020
Q2 		$208K Sell
21,277
-113
-0.5% -$1.04K ﹤0.01% 2478
2020
Q1 		$165K Buy
21,390
+204
+1% +$1.03K ﹤0.01% 2408
2019
Q4 		$82K Sell
21,186
-691
-3% -$3.01K ﹤0.01% 2825
2019
Q3 		$111K Buy
21,877
+989
+5% +$5.75K ﹤0.01% 2804
2019
Q2 		$138K Buy
20,888
+9,748
+88% +$67K ﹤0.01% 2803
2019
Q1 		$84K Buy
11,140
+1,135
+11% +$8.84K ﹤0.01% 2598
2018
Q4 		$81K Sell
10,005
-806
-7% -$8K ﹤0.01% 2457
2018
Q3 		$139K Sell
10,811
-11,354
-51% -$142K ﹤0.01% 2850
2018
Q2 		$253K Buy
22,165
+21,795
+5,891% +$206K ﹤0.01% 2932
2018
Q1 		$3K Sell
370
-891
-71% -$6.73K ﹤0.01% 4190
2017
Q4 		$8K Buy
+1,261
New +$8.02K ﹤0.01% 4032
2017
Q3 		– Sell
-1,600
Closed -$7K – 4249
2017
Q2 		$7K Sell
1,600
-180
-10% -$789 ﹤0.01% 3853
2017
Q1 		$8K Sell
1,780
-384
-18% -$2.15K ﹤0.01% 3678
2016
Q4 		$12K Buy
2,164
+180
+9% +$985 ﹤0.01% 3724
2016
Q3 		$13K Buy
1,984
+1,000
+102% +$5.2K ﹤0.01% 3634
2016
Q2 		$4K Buy
+984
New +$4.28K ﹤0.01% 3854

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CTSO Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 20,385 shares — an estimated $65K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CTSO in Q2 2016 and held it in 23 quarters. The position peaked at $253K in Q2 2018. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 20,385 Cytosorbents Corp shares in Q2 2022, an estimated $65K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cytosorbents Corp in Q2 2016 and held it in 23 quarters.
  • Manulife (Manufacturers Life Insurance)'s Cytosorbents Corp position peaked at $253K in Q2 2018.
  • 78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.